News

A new study in a recent issue of Diabetologia compares intermittent (flash) glucose monitoring with finger-prick testing in a group of pregnant women with type 1 diabetes. While flash did improve glycaemic c...

Tirzepatide is a new class of drug for management of type 2 diabetes. A meta-analysis of its glucose-lowering and weight-loss effects, presented in a recent issue of Diabetologia, will help guide treatment d...

A new analysis of the Global Burden of Disease study, presented in a recent issue of Diabetologia, reveals the geographical variation of type 2 diabetes and how risk factors for the associated morbidity and ...

Insulin allergy can cause significant challenges in diabetes treatment. A new paper in Diabetologia discusses the diagnosis and management of this rare, but important, condition. Dr Susan Aldridge reports.

A new analysis from the Adolescent Cardio-Renal Intervention Trial, reported in a recent issue of Diabetologia, shows that higher urinary albumin/creatinine ratio – even within the normal range –...

A new study, reported in a recent issue of Diabetologia, shows that dapagliflozin benefits people across a wide range of kidney disease severity. The findings, based on an analysis of the DAPA-CKD trial, tak...

Combining data from continuous glucose monitoring with self-care and mental health data could help improve diabetes care. A new review in Diabetologia looks at the emerging area of precision monitoring. Dr S...

Recent research suggests that pharmacoepigenetics may have clinical relevance in type 2 diabetes, from predicting who will respond to diabetes drugs to developing innovative therapies targeting epigenetic en...

Steroids, antipsychotics, antiretroviral therapy for HIV and immune checkpoint inhibitors against cancer: all of these may cause diabetes. A new review in Diabetologia looks at these four classes of diabetog...

If you’ve been following our Insulin in my country series, you might be interested in a commentary on the insulin market – past, present and future – which appears in a recent issue of Diab...

Understanding the psychology of severe hypos that are driven by hypoglycaemia unawareness could go a long way to alleviating this common complication of insulin therapy. A new paper in Diabetologia describes...

The threat posed by COVID-19 may be receding, but the diabetes pandemic rages on and now requires our full attention, according to an opinion piece in a recent issue of Diabetologia. A study in the same issu...

A new review in Diabetologia shines a light on the complex relationship between lipid lowering and diabetic retinopathy. Further understanding of retinal cholesterol metabolism, including the formation of ch...

Gestational diabetes can have a serious impact on the health of both mother and baby. But according to a recent review in Diabetologia,there is scope now for a more precise approach to its prevention based o...

Type 1 diabetes may begin with DNA changes that influence gene expression, according to a report in a recent paper in Diabetologia from researchers in Finland. And detection of this epigenetic signature coul...

An overemphasis upon biomedical science could prevent precision medicine from addressing health inequalities fully. As researchers try to move away from ‘one size fits all’ in healthcare, in a re...

A review in a recent issue of Diabetologia suggests there is more to prediabetes than just an increased risk of developing type 2 diabetes. Impaired glucose metabolism in prediabetes is also associated with ...

Modern lifestyles may have a detrimental effect on metabolism through exposure to bright and dim light at times that are out of sync with natural day-night rhythms. A study reported in a recent issue of Diab...

Restricting carbohydrate reduces HbA1cand glucose variability more than a conventional weight-loss diet does, according to a study from researchers in Denmark published in a recent issue of Diabetologia. Dr ...

We’ve come a long way in improving pregnancy outcomes for women with type 1 diabetes, but research continues and drug companies are advancing their insulin offerings. In the latest episode in our Insul...

A new study, reported in Diabetologia in January, tested the performance of 22 cardiovascular risk scores in primary care data from people with type 2 diabetes. The findings suggest these tools do not provid...